Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Nasdaq

One Of Apple's Biggest Streaming Hits Could Be Ending: What Investors Should Know

Technology giant Apple Inc (NASDAQ: AAPL) is one of the companies that has dove into the world of streaming. The company’s streaming platform AppleTV+ has trailed rivals in many metrics for viewership and subscribers.

Benzinga

American Airline's Regional Pilots Get Hefty Pay Raises As Competition Heats Up: CNBC

Regional carriers operated by American Airlines Group Inc (NASDAQ:AAL) intend to increase pilot compensation by 50% through the end of August 2024, the latest hint that airlines are willing to pay up in the hopes of ending a pilot shortage that has left some travelers with fewer flight options, reported CNBC. This will…

Benzinga

Donald Trump-Linked Stock Digital World Is Falling Today: Here's Why

Digital World Acquisition Corp (NASDAQ: DWAC) shares are trading lower Monday after the company filed a Form 8-K with the U.S. Securities and Exchange Commission showing it received another subpoena.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

$1000 Invested In This Stock 10 Years Ago Would Be Worth $3,500 Today

Honeywell Intl (NASDAQ:HON) has outperformed the market over the past 10 years by 2.4% on an annualized basis producing an average annual return of 13.13%. Currently, Honeywell Intl has a market capitalization of $125.85 billion.

Benzinga

Why Shares Of Datadog Are Falling Today

Datadog, Inc. (NASDAQ: DDOG) shares are trading lower Monday alongside several companies in the broader technology sector amid overall weakness as stocks continue to sell off following worse-than-expected May CPI data.

Benzinga

What's Going On With Starbucks Shares Trading Lower Again Today?

Starbucks Corporation (NASDAQ: SBUX) shares are experiencing selling pressure Monday afternoon, trading lower by 3.69% to $72.88. Shares of several hotel, restaurant & leisure companies are trading lower amid overall market weakness following worse-than-expected May CPI data.

Benzinga

What's Going On With Amazon Shares Nosediving Today?

Amazon.com, Inc (NASDAQ: AMZN) shares are experiencing marked weakness during Monday's trading session, trading lower by 5.03% to $104.13. Shares of companies in the broader consumer discretionary space are trading lower amid overall market weakness following worse-than-expected May CPI data.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

DocuSign 69.52% Down From All-Time Highs Despite Announced Microsoft Partnership

Shares of DocuSign (NASDAQ: DOCU) opened 23.78% lower at $66.5 on Friday after the e-signature software maker reported Q1 2023 adjusted earnings per share (EPS) that were below consensus estimates.

Benzinga

JPMorgan Sees Big Jump In Apple Gaming, Music Revenue

Apple Inc's (NASDAQ: AAPL) revenue from gaming and music offerings will likely jump 36% to $8.2 billion by 2025, JP Morgan said, as the iPhone maker taps its vast user base to drive its subscription services.

Benzinga

There Are 'A Lot Of Reasons' To Like This Semiconductor Stock Says Pete Najarian

Micron Technology, Inc. (NASDAQ: MU) was featured as the call of the day Monday on CNBC's "Fast Money Halftime Report."

Benzinga

Read Why Forma Therapeutics' Current Price Level Is 'Attractive Entry Point'

During the European Hematology Association (EHA) conference, Forma Therapeutics Holdings Inc (NASDAQ:FMTX) presented updated results from the 12-week open-label extension (OLE) of etavopivat's Phase 1 trial in sickle cell disease. Treatment with etavopivat 400mg QD elicited a >1g/dL hemoglobin (Hb) increase in 73% of the 15 patients and an average maximal Hb increase of…

Benzinga

Analysts Remain Bullish Despite Caribou's Allogeneic CAR-T Hit By Durability

Caribou Biosciences Inc (NASDAQ:CRBU) announced the presentation of additional initial clinical data from its ANTLER Phase 1 trial for CB-010 in relapsed or refractory B cell non-Hodgkin lymphoma (r/r B-NHL). Following a single dose at the initial dose level of 40 million CAR-T cells, a 100% complete response (CR) rate (6 of 6…

Benzinga

Sono-Tek Gears Up To Join Russell Microcap

Sono-Tek Corp (NASDAQ:SOTK) looks to join the Russell Microcap Index after the 2022 Russell Index annual reconstitution on June 27, as per FTSE Russell's preliminary list. Chair and CEO Dr. Chris Coccio said, "This inclusion also highlights the progress we have made during the past twelve months, which includes our uplisting to the…

Benzinga

RBC Shares Its Insight On Fintechs, Apple Buy Now Pay Later, Ultimate Winners

RBC Capital analyst Daniel. R. Perlin looked forward to the Fintech Conference on June 14. Investor feedback was generally constructive, with most investors focused on which names in its universe have the higher probability for positive revisions in 2H/22 versus names at risk.

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Mid-Afternoon Market Update: Gold Down Over 2%; Electric Last Mile Solutions Shares Plummet

U.S. stocks traded lower toward the end of trading, with the S&P 500 dropping by more than 3% on Monday.

Benzinga

Why Shares Of Cloud-Based Company Okta Are Trading Downwards

Okta, Inc. (NASDAQ: OKTA) shares are trading lower Monday alongside several companies in the broader technology sector amid overall weakness as stocks continue to sell off following worse-than-expected May CPI data.

Benzinga

Why Shares Of Atlassian Corporation Are Trading Lower

Atlassian Corporation PLC (NASDAQ: TEAM) shares are trading lower Monday alongside several companies in the broader technology sector amid overall weakness as stocks continue to sell off following worse-than-expected May CPI data.

Benzinga

Why Shares Of MercadoLibre Are Approaching 52-Week Lows

MercadoLibre, Inc. (NASDAQ: MELI) shares are trading lower Monday alongside several companies in the retail & apparel sector amid overall weakness as stocks continue to sell off following worse-than-expected May CPI data.

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Amber Heard's First Sit-Down Interview Coming This Week: Here's When And How To Watch

After losing the defamation trial ex-husband Johnny Depp brought against her, Amber Heard is set to share her thoughts on the case publicly in her first televised interview. Here are the details.

Benzinga

Barrington Hikes ICF Price Target By ~3%

Barrington analyst Kevin Steinke raised the price target on ICF International Inc (NASDAQ:ICFI) to $121 from $118 while maintaining the Outperform rating on the shares. The analyst raised the price target after reviewing the recent Q1 results and 2022 guidance reiteration. Steinke mentions that ICF recently held an Investor Day event focused on five key…

Benzinga

10 Information Technology Stocks Whale Activity In Today's Session

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.

Benzinga

$1000 Invested In This Stock 15 Years Ago Would Be Worth $8,400 Today

Alphabet (NASDAQ:GOOGL) has outperformed the market over the past 15 years by 9.0% on an annualized basis producing an average annual return of 15.23%. Currently, Alphabet has a market capitalization of $1.42 trillion.

Benzinga

Here's How Much $100 Invested In Gilead Sciences 15 Years Ago Would Be Worth Today

Gilead Sciences (NASDAQ:GILD) has outperformed the market over the past 15 years by 1.22% on an annualized basis producing an average annual return of 7.45%. Currently, Gilead Sciences has a market capitalization of $74.42 billion.

Benzinga

Analysts Consider CRISPR Therapeutics' Blood Disorder Trial Data Encouraging, Impressive

CRISPR Therapeutics (NASDAQ: CRSP) presented results from its ongoing Phase 1 COBALT-LYM CTX130 (exa-cel) trial, an allogeneic CAR-T cell therapy targeting CD70 for solid tumors and certain hematologic malignancies.

Benzinga

To Infinity And Not Saudi Arabia: 'Lightyear' Banned In Country Over Same-Sex Kiss

Highly anticipated movie “Lightyear” will not be released in two international territories. Here’s why the latest movie in the Toy Story franchise won’t be included there.

1 … 393 394 395 396

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.